Eliquis and Glivec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eliquis (apixaban) and Glivec (imatinib mesylate). Common drug interactions include renal impairment among females and myositis among males.

The phase IV clinical study analyzes what interactions people have when they take Eliquis and Glivec. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,861 Eliquis users. Check the latest studies of Eliquis.

What is Glivec?

Glivec has active ingredients of imatinib mesylate. eHealthMe is studying from 17,777 Glivec users. Check the latest studies of Glivec.



On Aug, 06, 2026

19 people who take Eliquis and Glivec together, and have interactions are studied.

Eliquis and Glivec drug interactions.

What are the common drug interactions of Eliquis and Glivec, by gender? *:

female:

  1. Renal impairment (severely reduced kidney function)
  2. Blood creatine phosphokinase increased
  3. Drug intolerance (drug sensitivity)
  4. Limb discomfort (discomfort in leg)
  5. Metastases to liver (cancer spreads to liver)
  6. Mobility decreased (ability to move is reduced)

male:

  1. Myositis (inflammation of the muscles)
  2. Pneumonia
  3. Agitation (state of anxiety or nervous excitement)
  4. Anal fistula
  5. Aortic arteriosclerosis (hardening of the aortic arteries)
  6. Arteriosclerosis (thickening and hardening of arteries)
  7. Asthenia (weakness)
  8. Bowen's disease (early stage of skin cancer)
  9. Carcinoid tumour of the gastrointestinal tract
  10. Cardiac valve disease (heart valve disease)

What are the common drug interactions of Eliquis and Glivec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Myositis (inflammation of the muscles)
  2. Renal impairment (severely reduced kidney function)
  3. Torticollis (a twisted neck in which the head is tipped to one side, while the chin is turned to the other)

What are the existing conditions these people have? *

  1. Gastrointestinal Stromal Tumor: 11 people, 57.89%
  2. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 6 people, 31.58%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.26%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 5.26%
  5. Pneumonia: 1 person, 5.26%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and Glivec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eliquis and Glivec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glivec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eliquis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glivec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on apixaban and imatinib mesylate (the active ingredients of Eliquis and Glivec, respectively), and Eliquis and Glivec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: